RelaiSanté, a Paris-based startup that says it can connect hospitals with home-care professionals in under 20 minutes, closed a €6 million seed round in late September led by Ternel, with Aquiti, Elaia and AFI Ventures joining. The company declined to share its valuation.
The pitch is straightforward, if ambitious: hospitals enter a patient's post-discharge needs into RelaiSanté's platform, and within 18 minutes the system routes that request to qualified nurses, physiotherapists or medical equipment suppliers in the patient's area. It's a two-sided marketplace aimed at a friction point that has vexed French healthcare administrators for years.
"We're building a coordination infrastructure between hospital and home to secure this transition," co-founder and chief executive Pierre Godet wrote in a LinkedIn recruitment post over the summer. The phrasing was careful, even bureaucratic, but the problem he described is acute. French emergency departments remain clogged in part because downstream discharge capacity lags, a reality the Ministry of Health flagged repeatedly in June and July 2026 communiqués. A November 2025 study by DREES, the health ministry's statistics arm, found that three in ten patients were readmitted following an initial hospital stay.
RelaiSanté operates at that seam. Hospitals and clinics use the platform to find independent nurses (known in France as IDELs), home-help services and medical equipment providers willing to take on newly discharged patients. The startup says 315 health establishments now use its service, along with 12,000 professionals, according to September coverage in the French tech publication Maddyness. That's up from 250 facilities and 10,000 professionals the company reported at SANTEXPO, a Paris healthcare conference held in May.
Recent posts on the company's LinkedIn feed name-checked clients including Centre Hospitalier Robert Boulin de Libourne, a clinic in the ELSAN network called Clinique du Renaisson, and facilities in the Inicea and Vivalto Santé groups. At SANTEXPO, the company claimed that 97 percent of providers respond the same day, and 91 percent of patient files close out within 0.7 days. Those are the kinds of metrics that draw attention in a system under strain.
The new capital will fund an expansion to 1,000 health establishments by next year, according to ProYarn, a French industry tracker. The company also plans to grow headcount from around 15 to 20 by year-end and broaden its offerings to include paramedical and medical equipment coordination. Artificial intelligence features for anticipating discharges are in the works, ProYarn reported, though the company has not detailed how those algorithms would function.
Godet shares leadership with co-founder Boix, who holds the title of president. The company operates from an office on Rue de Ponthieu in Paris's 8th arrondissement.
A Crowded Field
RelaiSanté is not alone in trying to solve hospital-to-home handoffs. France's national health insurance system, Assurance Maladie, runs PRADO, an institutional program that handles similar post-discharge coordination. That effort is not a marketplace, however, and operates within the constraints of a public bureaucracy.
Private competitors have emerged. Medicilio coordinates home care and equipment delivery. Entr'Actes focuses on primary-care coordination. Ville-Hôpital links medication delivery between hospitals and community pharmacies. Laé Santé offers home-return services. The landscape is fragmented, and no single player dominates.
That fragmentation may explain why AP-HP, the sprawling Paris public hospital system, issued a tender in September explicitly seeking a platform to "secure hospital discharge by identifying home professionals and facilitating coordination." The tender, which closed on September 14, listed coordination services and a marketplace for paramedical and home-equipment providers as separate procurement lots, suggesting the institution itself is still piecing together its post-discharge infrastructure.
The Investors
Ternel, the lead investor, is an impact-focused vehicle of Capital Croissance that writes checks between €500,000 and €5 million at seed and Series A stages. Aquiti, based in Nouvelle-Aquitaine, leads or co-leads early rounds up to €2 million and has followed on with as much as €6 million, according to the firm's website. AFI Ventures, Ventech's impact fund, invests €250,000 to €500,000 monthly at pre-seed and seed and carries an Article 9 designation under EU sustainable-finance regulations, a label reserved for funds with explicit social or environmental mandates. Elaia, the fourth participant, is a veteran early-stage investor with a longstanding seed practice.
Corporate filings from February show that Aquiti Venture Amorçage 1 and FPCI AFI Ventures were already party to RelaiSanté's incorporation documents, suggesting those relationships predated the September closing.
Revenue Model and Data Handling
The company's revenue model remains somewhat opaque. A SANTEXPO presentation in May described the platform as "100 percent free" for hospitals, which implies RelaiSanté charges home-care providers or captures value through another channel. The company has not disclosed pricing publicly, and a spokesperson did not respond to a request for clarification.
On data privacy, RelaiSanté's terms of service state that the platform stores no nominative health data and relies on GDPR-compliant pseudonymization and encryption. Patient information is hosted on HDS-certified servers in France, a regulatory requirement for handling health data under French law.
The startup ran a free trial for home-help services through the end of September, according to posts on its social channels. A back-end engineering role was advertised as recently as three months ago, a signal that the company is still building out core infrastructure even as it scales its customer base.
Whether RelaiSanté's 18-minute promise holds at scale remains to be seen. For now, the startup has backing, a growing network and a problem that isn't going away.
